Pharma Commercial Mock
← All views·CI feed·API docs
AASCO
Meeting Library
AACR Annual Meeting 2026 · San Diego, CA
5 shown of 8,318 total abstracts
  1. Abstract 97672026-04-04 · 15:30 CT · S406
    CheckMate-958: Opdivo (nivolumab) 2L in metastatic melanoma
    E. Winer, J. Cortes, C. Saura · Mayo Clinic
    Clinical Science SymposiumMelanoma📄🖼️
  2. Abstract 97662026-04-01 · 21:45 CT · Hall B1
    KEYNOTE-742: Keytruda (pembrolizumab) 2L in metastatic melanoma
    L. Paz-Ares, H. Borghaei · Stanford Cancer Institute
    Clinical Science SymposiumMelanoma📄🖼️
  3. Abstract 97382026-04-03 · 16:30 CT · Hall B1
    Real-world effectiveness of Keytruda vs standard of care in metastatic melanoma
    H. Rugo, N. Rizvi · Stanford Cancer Institute
    Clinical Science SymposiumMelanoma📄🖼️
  4. Abstract 95602026-04-05 · 21:15 CT · S100A
    Quality of life outcomes with Opdivo in patients with metastatic melanoma
    P. Schmid, S. Tolaney · Stanford Cancer Institute
    Clinical Science SymposiumMelanoma📄🖼️
  5. Abstract 97712026-04-05 · 15:45 CT · E450
    Opdivo plus chemotherapy in previously untreated metastatic melanoma: updated analysis from CheckMate-175
    M. Krop, M.C. Garassino, E. Winer, et al. · Cleveland Clinic
    Clinical Science SymposiumMelanoma📄🖼️
© 2026 American Society of Clinical Oncology · Citations follow JCO supplement format:J Clin Oncol 44, 2026 (suppl 17; abstr XXXX). Demo mock.